Clinical Trial Update: Patupilone Versus Doxorubicin in Patients With Ovarian, Primary Fallopian, or Peritoneal Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing patupilone to doxorubicin in ovarian, fallopian tube, or peritoneal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Neoplasms

Drugs mentioned

• Doxorubicin (doxorubicin)
• Patupilone (epothilone B)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Ovarian Cancer, Fallopian Tube Cancer | Phase 3 | Status: COMPLETED